A Study to Assess the Immune Response and Safety of a Vaccine Against Influenza in Adults 18 Years of Age and Older

NCT07121192 · clinicaltrials.gov ↗

PHASE2

Phase

ACTIVE_NOT_RECRUITING

Status

776

Enrollment

INDUSTRY

Sponsor class

Conditions

Influenza, Human

Interventions

BIOLOGICAL: Flu mRNA (Formulation A)
BIOLOGICAL: Flu mRNA (Formulation B)
COMBINATION_PRODUCT: Comparator 1
COMBINATION_PRODUCT: Comparator 2
COMBINATION_PRODUCT: Comparator 3

Sponsor

GlaxoSmithKline